ShiftPixy Announces Integration of OpenAI Technologies into Quelliv's Ask Dr. A Chatbot
03 March 2023 - 12:00AM
Business Wire
– Enhancing Customer Experience for Laser
Biomodulation Technology Services –
ShiftPixy, Inc. (Nasdaq: PIXY) (“ShiftPixy” or “the Company”), a
Miami-based national staffing enterprise which designs, manages,
and sells access to a disruptive, revolutionary platform that
facilitates employment in the rapidly growing Gig Economy, today
announced its involvement in integrating OpenAI technology Davinci
into Quelliv's Ask Dr. A Chatbot. The chatbot assists customers in
answering their queries about the technology used and services
offered by ShiftPixy customer Quelliv, a wellness company using
laser biomodulation as an alternative approach to promoting
healing.
Through this partnership, ShiftPixy is leveraging its expertise
in integrating beta OpenAI technologies to enhance Quelliv's Ask
Dr. A Chatbot which is helping customers learn more about Quelliv's
cutting-edge laser biomodulation technology and services. With
ShiftPixy's integration of OpenAI, the chatbot is becoming even
smarter and more efficient, providing customers with the most
relevant and up-to-date information about Quelliv's products and
services.
“We are thrilled to be working with Quelliv and integrating
OpenAI's advanced natural language processing technologies into Ask
Dr. A chatbot,” said Scott Absher, Co-Founder and CEO of ShiftPixy.
“This collaboration demonstrates the potential for AI to enhance
customer experiences and increase efficiency in a variety of
industries. We are excited to be at the forefront of this
development, and view this integration as a major milestone in
ShiftPixy’s commitment to leveraging advanced technologies to
enhance customer experiences and increase efficiency for our
national clients.”
OpenAI's beta technologies are still in development, and
ShiftPixy and Quelliv are committed to working together to ensure
that the integration is seamless and delivers the best possible
results for customers.
“The Quelliv technology has many unique biological applications
and the Ask Dr. A chatbot is our best way to provide an instant
response to complex customer questions,” said Mike Keyes, CEO of
Quelliv. “The integration of OpenAI technologies into Ask Dr. A
chatbot is perfect for our business and we are excited to work with
ShiftPixy to bring this exciting technology to our customers.”
To learn more about Quelliv services via Ask Dr. A, please
download the Quelliv app via Google Play or App Store.
About Quelliv
Quelliv was designed to introduce a proprietary, high value and
high efficacy photobiomodulation technology trained to address a
number of biological applications in the wellness market’s highest
demand subsectors. Quelliv’s trained laser technology is uniquely
applied to anti-aging, weight management, pain management and scalp
rejuvenation. The Company has launched its initial three south
Florida locations with two additional locations coming online in Q4
2022. The Company plans to launch a national rollout to major metro
markets in Q1 of 2023 with a goal of 500 company owned locations
throughout the US longer term.
About ShiftPixy
ShiftPixy is a disruptive human capital services enterprise,
revolutionizing employment in the Gig Economy by delivering a
next-gen platform for workforce management that helps businesses
with shift-based employees navigate regulatory mandates, minimize
administrative burdens and better connect with a ready-for-hire
workforce. With expertise rooted in management’s more than 25 years
of workers’ compensation and compliance programs experience,
ShiftPixy adds a needed layer for addressing compliance and
continued demands for equitable employment practices in the growing
Gig Economy.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. These forward-looking statements include, among other
things, statements regarding the anticipated use of proceeds from
the private placement, the anticipated closing date of the private
placement and the anticipated filing and effectiveness date for a
registration statement related to the resale of the common shares
and common shares underlying warrants from the private placement.
Although such forward-looking statements are based upon what
management of the Company believes are reasonable assumptions,
there can be no assurance that forward-looking statements will
prove to be accurate. If any of the risks or uncertainties,
including those set forth below, materialize or if any of the
assumptions proves incorrect, the results of the Company, could
differ materially from the results expressed or implied by the
forward-looking statements we make. The risks and uncertainties
include, but are not limited to, risks associated with the nature
of the Company’s business model; the Company’s ability to execute
its vision and growth strategy; the Company’s ability to attract
and retain clients; the Company’s ability to assess and manage
risks; changes in the law that affect the Company’s business and
its ability to respond to such changes and incorporate them into
its business model, as necessary; the Company’s ability to insure
against and otherwise effectively manage risks that affect its
business; competition; reliance on third-party systems and
software; the Company’s ability to protect and maintain its
intellectual property; and general developments in the economy and
financial markets. These and other risks are discussed in the
Company’s filings with the SEC, including, without limitation, its
Annual Report on Form 10-K, and its periodic and current reports on
Form 10-Q and Form 8-K. The Company undertakes no obligation to
update forward-looking statements if circumstances or management's
estimates or opinions should change, except as required by
applicable securities laws. The information in this press release
shall not be deemed to be “filed” for the purpose of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section, and will not be deemed
an admission as to the materiality of any information that is
required to be disclosed solely by Regulation FD. Further
information on these and other factors that could affect the
financial results of the Company, is included in the filings we
make with the SEC from time to time. These documents are available
on the “SEC Filings” subsection of the “Investor Information”
section of the Company’s website at
https://ir.shiftpixy.com/financial-information/sec-filings, or
directly from the SEC’s website at https://www.sec.gov. Consistent
with the SEC’s April 2013 guidance on using social media outlets
like Facebook and Twitter to make corporate disclosures and
announce key information in compliance with Regulation FD, the
Company is alerting investors and other members of the general
public that the Company will provide updates on operations and
progress required to be disclosed under Regulation FD through its
social media on Facebook, Twitter, LinkedIn and YouTube. Investors,
potential investors, shareholders and individuals interested in the
Company are encouraged to keep informed by following us on
Facebook, Twitter, LinkedIn and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230302005059/en/
INVESTOR CONTACT: InvestorRelations@shiftpixy.com
800.475.3655
ShiftPixy (NASDAQ:PIXY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ShiftPixy (NASDAQ:PIXY)
Historical Stock Chart
From Jul 2023 to Jul 2024